Rainbow Children's Medicare Reports Strong FY26 Results, Recommends Dividend

Rainbow Children's Medicare Limited has announced its financial performance for the fiscal year ending March 31, 2026. The company reported consolidated revenue of ₹1,703.08 crore, an increase from ₹1,515.87 crore in the previous year. Consolidated Profit After Tax (PAT) grew to ₹281.54 crore, up from ₹244.23 crore in FY25. The Board has recommended a final dividend of ₹3.5 per equity share, pending shareholder approval.

Financial Growth and Shareholder Returns

The company's financial results show a positive year marked by growth in both revenue and profit. This performance is attributed to operational improvements and strategic acquisitions. The proposed dividend signals a commitment to returning value to shareholders, while the re-appointment of key leadership, including the Chairman and Managing Director, as well as independent directors, ensures continuity and stability in governance.

Leadership Continuity

Key management personnel and independent directors have been re-appointed, ensuring stability for the next five years. Dr. Ramesh Kancharla will continue as Chairman and Managing Director, and Dr. Dinesh Kumar Chirla will remain as Whole Time Director. This continuity is expected to support the company's strategic objectives.

Impact of New Labour Codes

An exceptional item of ₹1.54 crore was recorded due to increased provisions for employee benefit obligations. This was a one-time charge resulting from the implementation of new Labour Codes and slightly impacted the reported annual profit.

Future Focus

Investors will be watching the successful integration of recent acquisitions, Prashanthi Medicare Private Limited and Pratiksha Women & Child Care Hospital Private Limited. The company's ability to maintain its growth momentum and manage operational efficiencies will be crucial for its future performance.